This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA®
Bladder Cancer Detection
CORE-001 Study
EV-302
Immunotherapy in NMIBC
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Urologic Catheters (Includes CAUTI)
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Bladder Cancer
LG-IR NMIBC
Adstiladrin®
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AUA 2025
PSMA and Beyond 2025 Conference
EAU 2025
SES AUA 2025
Thought Leaders 2025
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy - Abstract
May 25, 2011
BJUI Mini Reviews - Focal therapy in the management of localized prostate cancer
May 25, 2011
The Association between pre-operative PSA and prostate cancer-specific mortality in patients with long-term follow-up after radical prostatectomy - Abstract
May 24, 2011
Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer - Abstract
May 24, 2011
Prostate cancer risk variants are not associated with disease progression - Abstract
May 24, 2011
Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥12)-core prostate biopsy - Abstract
May 24, 2011
Treatment decision-making for localized prostate cancer: What younger men choose and why - Abstract
May 24, 2011
Molecular chemotherapy and Chemotherapy: A new front against late stage hormone refractory prostate cancer - Abstract
May 24, 2011
Combination therapy of recurrent prostate cancer with the proteasome inhibitor Bortezomib plus hormone blockade - Abstract
May 24, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer - Abstract
May 24, 2011
Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers - Abstract
May 24, 2011
The role of brachytherapy in the definitive management of prostate cancer - Abstract
May 23, 2011
3D conformal radiation therapy and hormonal therapy for localized prostate cancer: Is age a limiting factor? - Abstract
May 23, 2011
Investigating the clinical aspects of using CT vs. CT-MRI images during organ delineation and treatment planning in prostate cancer radiotherapy - Abstract
May 23, 2011
Effect of testosterone administration to men with prostate cancer is unpredictable: A word of caution and suggestions for a registry - Abstract
May 23, 2011
Serum phospholipid fatty acids and prostate cancer risk: Results from the Prostate Cancer Prevention Trial - Abstract
May 23, 2011
Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study - Abstract
May 23, 2011
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men - Abstract
May 23, 2011
Active surveillance for low-risk prostate cancer: An update - Abstract
May 23, 2011
Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting - Abstract
May 23, 2011
Page 1433 of 1473
Start
Prev
1428
1429
1430
1431
1432
1433
1434
1435
1436
1437
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free